SC
DGX icon

Saiph Capital’s Quest Diagnostics DGX Stock Holding History

Saiph Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$704K Buy
+3,322
New +$652K 0.21% 52

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Saiph Capital's DGX Position: Q2 2026 in Review

Saiph Capital opened a new position in Quest Diagnostics (DGX) in Q2 2026: 3,322 shares worth $704K. The stake represents 0.21% of the portfolio and ranks #52 among its holdings.

444 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Saiph Capital held 3,322 shares of Quest Diagnostics worth $704K as of Q2 2026.
  • Quest Diagnostics was a new Saiph Capital position in Q2 2026.
  • Quest Diagnostics made up 0.21% of Saiph Capital's portfolio in Q2 2026, its #52 holding.
  • 444 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Saiph Capital's 13F filing for Q2 2026, filed 29 Jul 2026.